POST https://chat.qwen.ai/api/chat/completions HTTP/2.0
content-length: 414
x-request-id: f5db35f2-c75e-4216-8151-a92c62b19204
authorization: Bearer eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJpZCI6IjNmNDk1MTU1LTE0YzItNDkwOS05OWM5LTg3Y2JhNzc2ODc5NiIsImV4cCI6MTc0NDI0NTExOH0.nuqvEz2ng6UPFSiNUPKufz44vAa_jSYeFckK7AE90bQ
bx-umidtoken: T2gAF00p1odMS16oXaYGvtq_r59DY5IYp-oQcCUY_AsPqGjTbH-XS9tgZx2You4xNQs=
x-accel-buffering: no
sec-ch-ua: "Chromium";v="134", "Not:A-Brand";v="24", "Google Chrome";v="134"
bx-ua: 231!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
sec-ch-ua-mobile: ?0
sec-ch-ua-platform: "macOS"
source: web
user-agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_15_7) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/134.0.0.0 Safari/537.36
content-type: application/json
version: 0.0.51
bx-v: 2.5.28
accept: */*
origin: https://chat.qwen.ai
sec-fetch-site: same-origin
sec-fetch-mode: cors
sec-fetch-dest: empty
referer: https://chat.qwen.ai/
accept-encoding: gzip, deflate, br, zstd
accept-language: en-US,en;q=0.9
cookie: _gcl_au=1.1.1107515031.1741652677
cookie: cna=xnBWIPKbnggCAUQ9ZB+fldjs
cookie: _bl_uid=szmF38a75549Lm3Ldrzb4OhwasX3
cookie: acw_tc=e1ccc49392617ab0bce6581d571b79554751d94346afb4fbb6895375845e701b
cookie: x-ap=us-west-1
cookie: xlly_s=1
cookie: token=eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJpZCI6IjNmNDk1MTU1LTE0YzItNDkwOS05OWM5LTg3Y2JhNzc2ODc5NiIsImV4cCI6MTc0NDU4MDU0OX0.fw4nZx_0KqO2ejTG0bi2MrKNhXDmClHi7W43LKSrd-I
cookie: ssxmod_itna=eqAxgDBD07SD9Dmxe90DfxP=NDOrG2Deq0dGMD3Te7UtGcD8o40P8+tRxGkYjiiUCY4GOKmwitDl=B4oWDCqKGfDQPEYeWmMhtPHK7OOe1KQFAkbQNFtG7R57bI=E+peiLtHTD==xeGmz4DSixD9YxxbDYYDC4GwDGoD34DiDDPPxDUQdePD7hRKwjRZir0o3mbDm4ftixDgGPD141utECXYDafvFoTWDxGnD0jGrEq3x037Ho7DzMoDboo519ODtM9DxOIdcmTW+ImhfwCbn3+eX7E+i0GjKSxm0+Gq3Rxm+XzqY5AhRgCxeoDDf2r+gEP4QmYi+fh=6ZeUhYZiv3F56j0xQeGehnOeKUwzmDGChQCxqi+TRhMehd0iPYD
cookie: ssxmod_itna2=eqAxgDBD07SD9Dmxe90DfxP=NDOrG2Deq0dGMD3Te7UtGcD8o40P8+tRxGkYjiiUCY4GOKmwDoDirSRI5QoCx03q5t6o5DlaBhW7NIbDr9hNS3rSGYYi+PrtPbqt6Sc=w5QizWfFpb7LBz0DZ+ivBY7A6nk04NQ=bWB+RW7dDaBxP5irQs7dtsD04Rfu6UGn5n2bWN1TFHPuFxaFb3dRkwY5zlxAdRB4qUaxbR=HPeD
cookie: SERVERID=a852673086f1354c2f4c6ea3f9eee45e|1741988556|1741988381
cookie: tfstk=gNgSMBbZNv3V7a6mZLd4G59UQYaQVvTaN6NKsXQP9zU8d6ME6kFPzQmIcvk7evGHZWeKpvwE4n8ZZb43JdkB7Flo3OK2fvZ8JZBxiWb89nr-i3B2gdJw7Ek2cPgXQYyMfCxbt-F89WFJGiFQwyF89udbHWNGvTHLJIOb9W6dykF8DSFutyeKpydjM-VBr15Qgd2mNQnNlnohloh8hwQKy34uCbjF-w0bNjgKw-1VgqN7VRZcL28t5fh-SWgH6MwIT0HzivT6hr3SF4EbRe_0zfixFoiWdZZmDf0Lcmv1jfc-FcEtyEOmdxhijz3JKayovj3L34dFRRnZsrNm8Kb8dmnKzu4heLNjPfgIAg7O7RG3tM1bjwNbQIOfxMbIgPznjn41XuF0g3RXGGrQ2SVbuIOfxMq8iSk9GIsM6
cookie: isg=BAAA8vRWcxeUkQ8IqEffOaWi0YjSieRTXywDcnqRz5uu9aMfMJ2V4ppDCUU1xZwr
priority: u=1, i

{"stream":true,"incremental_output":true,"chat_type":"search","model":"qwen-max-latest","messages":[{"role":"user","content":"2008年肝素污染危机的责任人是谁？","chat_type":"search","extra":{},"feature_config":{"thinking_enabled":false}}],"session_id":"1a8514bf-fca9-4e31-9c50-ef0a2fe7d54c","chat_id":"a17b7f48-6dae-45c6-9c23-d7f3b82249b6","id":"b2b36cba-5453-40cc-b52b-8cffe7f4e1c2","size":"960*960"}HTTP/2.0 200 
date: Fri, 14 Mar 2025 21:42:40 GMT
content-type: text/event-stream;charset=UTF-8
vary: Accept-Encoding
access-control-allow-credentials: true
access-control-allow-origin: https://chat.qwen.ai
vary: Origin
x-request-id: f5db35f2-c75e-4216-8151-a92c62b19204
cache-control: no-cache
set-cookie: x-ap=us-west-1; Path=/; SameSite=lax
x-process-time: 3
set-cookie: SERVERID=a852673086f1354c2f4c6ea3f9eee45e|1741988557|1741988381;Path=/
set-cookie: SERVERCORSID=a852673086f1354c2f4c6ea3f9eee45e|1741988557|1741988381;Path=/;SameSite=None
content-encoding: br
ga-ap: us-west-1

data: {"choices": [{"delta": {"role": "assistant", "content": "", "function_call": {"name": "web_search", "arguments": ""}}}]}

data: {"choices": [{"delta": {"role": "function", "content": "", "name": "web_search", "extra": {"web_search_info": [{"url": "https://international.caixin.com/2008-04-30/100062586.html", "title": "美国会质询“肝素钠不良反应事件”", "snippet": "Apr 30, 2008 · 据美国药监局统计，已有785宗注射问题肝素钠后出现严重过敏反应的病例，另有81宗死亡病例。 今年2月，美国药监局曾派员赴美国SPL在中国的控股企业常州凯普进 Missing:  责任 | Show results with:责任", "hostname": "财新网", "hostlogo": "https://img.alicdn.com/imgextra/i2/O1CN01oWqr251caB9yMliXs_!!6000000003616-73-tps-16-16.ico", "date": ""}, {"url": "https://news.cnyes.com/news/id/2700401", "title": "FDA\"警告信\"再添14家中企肝素鈉出口二次危機 - 鉅亨", "snippet": "Feb 28, 2012 · 2008年初，美國百特公司生產的肝素系列產品在美國引發多人死亡的嚴重不良反應，為其提供原料的常州凱普公司隨即被禁止向美出口。雖然常州凱普是美國SPL和 Missing:  责任 | Show results with:责任", "hostname": null, "hostlogo": null, "date": ""}, {"url": "https://q.stock.sohu.com/cn,gg,002399,1703423197.shtml", "title": "公司公告-海普瑞：重大资产购买报告书（草案）摘要 - 搜狐股票", "snippet": "责任。 （四）肝素事件相关诉讼风险2008 年的肝素事件引发了针对肝素制剂及原料生产厂商百特公司、SPL 等的大量诉讼。截至《股权购买协议》签署之日", "hostname": "搜狐", "hostlogo": "https://img.alicdn.com/imgextra/i2/O1CN01veTqEW21FRbz3biWe_!!6000000006955-55-tps-32-32.svg", "date": " (2014-01-13)"}, {"url": "https://news.cnyes.com/news/id/2700401", "title": "FDA\"警告信\"再添14家中企肝素鈉出口二次危機 - 鉅亨", "snippet": "2008年初，美國百特公司生產的肝素系列產品在美國引發多人死亡的嚴重不良反應，為其提供原料的常州凱普公司隨即被禁止向美出口。雖然常州凱普是美國SPL和", "hostname": null, "hostlogo": null, "date": " (2012-02-28)"}, {"url": "https://jcpu.cpu.edu.cn/cn/article/pdf/preview/10.11665/j.issn.1000-5048.20220316.pdf", "title": "[PDF] 《动物来源药用辅料指导原则》解析 - 中国药科大学学报", "snippet": "以2008 年发生在美国的“肝素钠”事. 件为例，美国百特公司生产的多批次肝素钠多剂. 量瓶装注射液中检出一种类肝素物质污染物多. 硫酸软骨素，并被证明与患者注射后发生过敏", "hostname": null, "hostlogo": null, "date": ""}]}}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "200"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "8年肝素污染危机"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "是一起严重的药品"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "安全事件，涉及美国百"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "特公司（Baxter）"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "生产的肝素系列产品"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "，这些产品在美国"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "引发了多人死亡和"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "严重过敏反应。事件的核心"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "问题在于肝素"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "钠原料中被"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "发现含有污染物多"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "硫酸软骨素"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "（一种类肝素"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "物质），这与患者的"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "不良反应直接相关[["}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "5]]。\n\n关于"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "责任的归属，可以从"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "以下几个方面分析：\n\n1."}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": " **常州凯普公司"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "（原料供应商）**"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "  \n   为"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "美国百特公司提供"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "肝素钠原料的是"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "其控股企业——"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "中国常州凯普"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "公司。事件发生后，"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "常州凯普因"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "质量问题被禁止向美国出口"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "肝素钠[["}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "2]]。作为"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "原料供应商，常州凯普"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "在生产和质量控制环节"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "可能存在疏漏，"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "是事件的主要责任"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "方之一。\n\n2."}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": " **美国百特公司（"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "制剂生产商）**  \n  "}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": " 百特公司作为肝"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "素系列产品的最终"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "生产商，未能有效"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "检测出原料中的污染物"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "，导致问题产品流入市场"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "。尽管其依赖"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "供应商提供原料，但"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "作为品牌持有者，百"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "特公司对产品质量负有"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "最终责任[[1"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "]]。\n\n3. **美国"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "SPL公司（中间"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "商）**  \n   "}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "常州凯普是"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "美国SPL公司"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "在中国的控股企业，"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "SPL公司在供应链管理中"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "也扮演了重要角色"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "。然而，在肝素事件"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "中，SPL公司未能"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "确保其控股企业的"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "生产符合国际标准，因此"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "也被牵涉进"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "责任争议[[2]]"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "。\n\n4. **监管"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "机构的责任**  \n  "}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": " 美国食品药品监督管理"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "局（FDA）在事件"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "中被认为存在监管漏洞"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "。例如，FDA在"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "对常州凯普进行"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "检查时未能及时"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "发现问题，暴露出其"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "对中国供应商监管的"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "不足[[1]]。\n\n###"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": " 总结  \n"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "2008年肝"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "素污染危机的责任主要由"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "多方共同承担："}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "  \n- **常州凯普"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "公司**作为原料供应商，"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "未能确保原料质量。"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "  \n- **美国百特"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "公司**作为最终生产商，"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "未能发现污染物并"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "阻止问题产品上市"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "。  \n- **美国S"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "PL公司**作为中间商"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "，未能有效监督其"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "控股企业。  \n- **"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "FDA**在监管过程中存在"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "疏漏，未能提前"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "预警风险[[3"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "]]。\n\n这一事件揭示了"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "全球药品供应链中"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "各环节的责任分配"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "问题，并促成了后续"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "对药用辅料"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "和原料质量管理的"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "更严格规范[[5"}}]}

data: {"choices": [{"delta": {"role": "assistant", "content": "]]。"}}]}

